ITGAX and Hepatic fibrosis: Indeed, apart from the elevated expression of IDO1 in fibrotic livers, the frequency of hepatic CD11c+DCs reduced from ~39.1% in controls to ~16.2% in BDLs and undergo a transformation in mature phenotype in BDL-induced liver fibrosis.